日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SHR-A1811, a novel HER2-targeting antibody-drug conjugate, in advanced solid tumors (HORIZON-X): a global phase 1 trial

SHR-A1811,一种新型靶向 HER2 的抗体药物偶联物,在晚期实体瘤中的应用(HORIZON-X):一项全球 1 期试验

Yao, Herui; Yan, Min; Tong, Zhongsheng; Wu, Xinhong; Yin, Yongmei; Ryu, Min-Hee; Park, John J; Jiang, Shusuan; Kim, Jee Hyun; Wang, Shouman; Zhong, Yahua; Voskoboynik, Mark; Zhang, Jian; Kaubisch, Andreas; Liu, Caigang; Chen, Yu; Im, Seock-Ah; Wu, Lingying; Liu, Yingbin; Ganju, Vinod; Barve, Minal; Li, Hui; Yao, Guangyu; Yang, Mudan; Bao, Lequn; Zhao, Yiming; Zhao, Jianli; Zhao, Kaijing; Shen, Yu; Rong, Shangyi; Zhu, Xiaoyu; Song, Erwei

Pyrotinib or placebo in combination with trastuzumab and docetaxel for HER2 positive metastatic breast cancer: long term survival results from randomised phase 3 PHILA trial

吡咯替尼或安慰剂联合曲妥珠单抗和多西他赛治疗HER2阳性转移性乳腺癌:随机3期PHILA试验的长期生存结果

Ma, Fei; Yan, Min; Li, Wei; Ouyang, Quchang; Tong, Zhongsheng; Teng, Yuee; Wang, Yongsheng; Wang, Shusen; Geng, Cuizhi; Luo, Ting; Zhong, Jincai; Zhang, Qingyuan; Liu, Qiang; Zeng, Xiaohua; Sun, Tao; Mo, Qinguo; Zhou, Shoubing; Li, Peidong; Cheng, Jing; Wang, Xiaojia; Nie, Jianyun; Yang, Jin; Wu, Xinhong; Wang, Xinshuai; Li, Huiping; Yao, Guangyu; Fan, Yang; Lin, Jiaman; Zhu, Xiaoyu; Xu, Binghe

Preoperative Chemoradiotherapy versus Chemotherapy for Locally Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma: A Phase III Randomized Controlled Trial from China

局部晚期胃癌或胃食管交界处腺癌术前放化疗与单纯化疗的疗效比较:一项来自中国的III期随机对照试验

Liu, Xiaowen; Jin, Jiejie; Zhou, Menglong; Zhou, Ye; Cai, Hong; Huang, Hua; Yan, Min; Yang, Zhongyin; Feng, Runhua; Lu, Qi; Ding, Hao; Xu, Hongtao; Liu, Xuexiao; Li, Guichao; Zhu, Hui; Sheng, Weiqi; Yang, Xiujiang; Zhang, Zhen; Wang, Yanong

Author Correction: Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype

作者更正:核内AURKA获得不依赖于激酶的转录激活功能,从而增强乳腺癌干细胞表型

Zheng, Feimeng; Yue, Caifeng; Li, Guohui; He, Bin; Cheng, Wei; Wang, Xi; Yan, Min; Long, Zijie; Qiu, Wanshou; Yuan, Zhongyu; Xu, Jie; Liu, Bing; Shi, Qian; Lam, Eric W-F; Hung, Mien-Chie; Liu, Quentin

Delta Opioid Receptors within the Cortico-Thalamic Circuitry Underlie Hyperactivity Induced by High-Dose Morphine

皮质-丘脑回路中的δ阿片受体是高剂量吗啡诱发过度活跃的基础

Li, Chun-Yue; Huang, Huiqian; Shen, Xiao-Fan; Cao, Ke-Lei; Zheng, Di; Zhu, Yi; Xie, Shi-Ze; Yu, Xiao-Dan; Wang, Hao; Chen, Jia-Dong; Shi, Jie; Li, Yue; Yan, Min; Li, Xiao-Ming

Intraperitoneal and intravenous paclitaxel plus S-1 and sintilimab as first-line treatment for gastric cancer with peritoneal metastasis: a single-arm phase 2 trial (DRAGON-09)

腹腔内和静脉内注射紫杉醇联合 S-1 和信迪利单抗作为一线治疗胃癌腹膜转移:一项单臂 2 期试验 (DRAGON-09)

Yuan, Hong; Lu, Sheng; Sun, De-Bin; Yao, Xue-Xin; Liu, Wen-Tao; Zheng, Ya-Nan; Hua, Zi-Chen; Ni, Zhen-Tian; He, Chang-Yu; Wang, Zhen-Qiang; Zhang, Jiao; Liu, Di; Jiang, Cen; Li, Chen; Zhang, Jun; Yan, Min; Yang, Zhong-Yin; Shi, Min; Zhu, Zheng-Gang; Yan, Chao

Inetetamab plus camrelizumab and utidelone for pretreated HER2-positive advanced breast cancer: a prospective, single-arm, phase 2 study

伊奈妥单抗联合卡瑞利珠单抗和乌替德隆治疗既往接受过治疗的HER2阳性晚期乳腺癌:一项前瞻性、单臂、II期研究

Lv, Huimin; Sun, Tao; Ling, Xiaoling; Liu, Xinlan; Yang, Jin; Zhang, Mengwei; Niu, Limin; Chen, Shumin; Liu, Zhenzhen; Wang, Chengzheng; Sun, Huihui; Wang, Jing; Zeng, Huiai; Zhao, Shengnan; Guo, Lanwei; Feng, Yajing; Zhang, Zhiqing; Xia, Qingxin; Qiu, Rongguo; Yan, Min

Changing donors improves outcomes of second transplantation in patients who experienced graft failure after first allogeneic stem cell transplantation

对于首次异基因造血干细胞移植后出现移植物衰竭的患者,更换供体可以改善第二次移植的预后。

Ma, Rui; Zhu, Xiao-Yu; Lu, Yue; Chen, Jia; Xuan, Li; Yuan, Hai-Long; Cao, Yang; Cao, Wei-Jie; Fang, Xiao-Sheng; Miao, Kou-Rong; Hu, Xiao-Xia; Yi, Hai; Zhao, Yan-Min; Wu, Yuan-Bin; Yang, Ting; Wang, Hong-Tao; Yin, Yue; Zhang, Zhong-Ming; Zhang, Xiao-Hui; Xu, Lan-Ping; Wang, Yu; Liu, Kai-Yan; Huang, Xiao-Jun; Sun, Yu-Qian

Lipid Peroxidation Products 4-ONE and 4-HNE Modulate Voltage-Gated Sodium Channels in Neuronal Cell Lines and DRG Action Potentials

脂质过氧化产物 4-ONE 和 4-HNE 调节神经元细胞系和 DRG 动作电位中的电压门控钠通道

Yin, Ming-Zhe; Park, Na Kyeong; Seo, Mi Seon; An, Jin Ryeol; Kim, Hyun Jong; Woo, JooHan; Kim, Jintae; Yan, Min; Kim, Sung Joon; Choi, Seong Woo

MTG2 as a Causal and Druggable Target in Uveal Melanoma via Mitochondrial DNA Dynamics: Evidence From Functional Validation and DMSA Identification

MTG2通过线粒体DNA动力学成为葡萄膜黑色素瘤的致病靶点和可成药靶点:来自功能验证和DMSA鉴定的证据

Zhang, Yan; Min, Daliu; Wang, Yonggang; Yu, Wenxi; Cui, Bowen; Su, Yuying; Shen, Zan; Feng, Changzhou